| INTRODUC TI ON
highly proliferative colonies, and are present in different numbers in several populations. 6, 7 To illustrate this, in patients with pulmonary arterial hypertension (PAH), the mean value of ECFC colonies is 1 per 
| NOMEN CL ATURE FOR ENDOTHELIAL PROG ENITOR CELL S IN CULTURE
The panel discussed the most suitable name to be used to refer to this population of progenitor cells, to avoid the confusion caused by differences in nomenclature. Over the last two decades, several 
| Recommendation 1
• The term "ECFC" should preferably be used in all subsequent studies.
| K E Y ME THODOLOG I C AL S TEPS IN THE ISOL ATI ON OF ECFC S FROM B LOOD -DERIVED MN C S
Blood is collected in either EDTA-containing, citrated or heparincontaining tubes. Isolation of MNCs is conducted with a 1.077 density gradient step.
The first change of medium occurs between day 2 and day 5 after MNC plating. Also, the time to appearance of the first colony is approximately 7 days for cord blood and 21 days for adult blood. The panel discussed the problem of the definition of colony F I G U R E 1 Quantification of endothelial colony-forming cells (ECFCs) in health and disease. A, Umbilical cord blood yields higher numbers of ECFC colonies than adult blood. In children (median age of 2 years), ECFC levels were higher than in adults. The association between age and ECFC levels appears to be lost in older subjects, and no significant differences were observed among subjects aged 20-73 years. ECFC levels have been examined in patients with von Willebrand disease (VWD) and with respiratory diseases, including pulmonary hypertension (PAH), chronic obstructive pulmonary disease (COPD), and idiopathic pulmonary fibrosis (IPF). In these patient groups, ECFC levels (colony numbers) did not appear to be significantly different from those in the healthy controls. For IPF patients, two separate cohorts comparing 5% (IPF-1) and 10% fetal bovine serum (FBS) (IPF-2) were compared and no differences in ECFC numbers were found. B, Levels of zero ECFC colonies were compared with the mean of the whole population (χ 2 test or Fisher's exact test when the number of zero colonies was <5). In healthy volunteers, the levels of zero ECFC colonies were significantly lower in the 0-10-year age group than in older groups (P = 0.05). In other populations, only VWD patients had significantly fewer zero ECFC colonies. For the IPF-1 and IPF-2 populations, we found that IPF-1 patients (with culture performed in EGM2-5% FBS) had more zero ECFC colonies than IPF-2 patients (with culture performed in 10% FBS). MNC, mononuclear cell Commercially available EGM2 is consistently used as the culture medium. The medium is usually supplemented with 5%-10% fetal bovine serum (FBS), and this range of FBS appears to produce no significant differences in the number of ECFC colonies. A study that compared 5% and 10% FBS on samples from two separate cohorts of patients with idiopathic pulmonary fibrosis (IPF) (IPF-1 and IPF-2 in Figure 1A ) found no significant differences in the numbers of isolated ECFCs when different amounts of FBS were used; however, a difference in the number of samples that failed to yield ECFC colonies ("zero colonies") was observed ( Figure 1B) . 
| Recommendation 2
• ECFC colonies should be identified as well-circumscribed colonies with a cobblestone appearance and with more than 50 adherent cells.
• ECFC levels should be expressed as the number of colonies per 10 7 MNCs seeded.
• Currently, expert laboratories report a success rate of 70%-75% in isolating ECFCs from peripheral blood of healthy subjects. Lack of success in isolating ECFCs from some subjects is to be expected.
Failure to isolate ECFC colonies (defined as "zero colonies") is a result that needs to be reported.
| HOW TO S TANDARD IZE PA SSAG E N UMB ER AND CELL E XPAN S I ON
Delayed colony appearance is a challenge that affects further subculture and thus the inferred age of the cells. 
| Recommendation 3
• The extent of expansion of ECFCs should be characterized not only by passage number, but also by PD time.
• ECFC studies should report the number of days in culture from the day of the original MNC isolation (day 0).
| HOW TO S TUDY ECFC S IN HE ALTH AND D IS E A S E
In healthy subjects, a very young age appears to affect ECFC levels and properties. Umbilical cord blood yields higher numbers of ECFC colonies than adult blood. 21 ECFC levels in children (median age of 2 years) were reported to be higher than those in adults (4.2 colonies per 10 7 MNCs seeded; n = 15; Figure 1A ). 6 The association between age and ECFC levels appears to be lost in adult subjects, as no significant differences in ECFC isolation efficiency and function were observed among subjects aged 20-73 years, with the exception of the "zero colonies" category (discussed below ECFC levels did not appear to be significantly different from those in healthy controls ( Figure 1A ).
In some subjects, the isolation procedure yields no colonies-referred to as "zero colonies". By the use of data from three laboratories (those of Smadja, Sabatier, and Randi), levels of zero ECFC colonies were compared with the mean of the whole population. In healthy volunteers, we found fewer subjects yielding zero colonies in the 0-10-year age group than in older groups. In disease populations, only VWD patients have significantly fewer zero colonies than the whole population. This might be linked to the angiogenic properties described for von Willebrand factor.
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For the IPF-1 and IPF-2 populations, although the median range of ECFCs is similar ( Figure 1A) , we found than IPF-1 patients (with culture performed in EGM2-5% FBS) have more zero ECFC colonies than IPF-2 patients (with culture performed in 10% FBS). Thus, the amount of FBS could be a major determinant of the appearance of ECFCs in culture. Whether this holds true in other clinical situations, such as diabetes, remains to be determined. 26 Often, particularly in vascular genetic disorders, the main changes are not in the levels of ECFCs but in some of their functional properties, including proliferation capacity, vesiculation, and the onset of senescence. [27] [28] [29] Alternative measures for regenerative potential need to be explored, including expression of immaturity markers, 5,30 the in vivo ability to form stable vessels, 31 and long-term proliferation.
Importantly, in studies on umbilical cord blood, the health status of the mother needs to be considered. For example, studies have
shown that cord blood levels of ECFCs are lower in women with pre-eclampsia than in healthy control pregnancies. The panel discussed the issue of donor reproducibility. Generally, it was agreed that donors who yield ECFCs appear to do so consistently in repeated isolations. Likewise, some donors do not yield ECFCs consistently. Reproducibility is important, considering that the presence of ECFCs has been proposed as a marker of preserved microvascular integrity in patients after acute myocardial infarction. 34 The panel agreed on the need to report the ability to isolate ECFCs-i.e., presence or absence of colonies-in clinical studies, which may be as important as the actual number of ECFC colonies obtained (see also Recommendation 2).
| Recommendation 4
• ECFC levels decrease progressively from birth to adulthood, although the rate at which this variation occurs is unclear. Thus, in adults, age does not seem to be a major determinant of ECFC levels.
• ECFCs represent a valuable tool for investigating endothelial function in disease. The functional assessment and number of zero colonies of ECFCs are likely to be more informative than ECFC levels (number of colonies), and thus these cells should be profiled for their molecular signatures and studied with appropriate standardized functional assays.
In summary, the ISTH-SSC workshop identified a number of criteria that are required to increase the reliability of ECFC studies and to reduce interlaboratory discordances. However, some methodological aspects that are difficult to standardize, such as the time between colony appearance and first passage, need to be validated in order to enable comparison of data from multicenter studies. Moreover, preanalytic factors (circadian fluctuations, fasting, exercise, nutrition, etc.) should be considered as areas that could be improved in the future for ECFC standardization. Given the increasing interest in using ECFCs as liquid biopsies, and the prospect of using ECFCs in cell therapy trials for ischemic retinopathies 9 and ischemic heart disease, 35 standardization is urgently needed.
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